Virginia Expects About $530 Million in Opioid Crisis Settlement from Drug Distributors and Johnson & Johnson

Virginia expects about $530 million in a settlement over the opioid crisis with Johnson & Johnson along with pharmaceutical distributors Cardinal Health, McKesson, and AmerisourceBergen, according to a press release from the Office of the Attorney General. The companies announced Friday that there is enough participation by states, territories, and localities who were suing the drug companies to move forward with a national settlement, first announced in July 2021.

In his release, Attorney General Jason Miyares said, “The opioid crisis has devastated many Virginia communities, families, and lives. The Office of the Attorney General is dedicated to this fight and is proud to have played a role in this historic settlement, which every city and county in Virginia joined. Because of this, the Commonwealth expects to receive approximately $530 million dollars to fight back against the opioid epidemic and support efforts to reduce, prevent and treat opioid addiction.”

Read More

Nearly 75 Percent of Pennsylvania Counties Have Signed Onto Opioid Settlement

pill bottles spilled onto a table

Fifty Pennsylvania counties have joined a historic global opioid settlement that is expected to bring $1 billion to the state to fight the opioid crisis.

The $26 billion settlement involves the nation’s three major pharmaceutical distributors – Cardinal, McKesson and AmerisourceBergen – as well as Johnson & Johnson. The agreement requires industry changes to help prevent a similar crisis in the future, in addition to the funds, Pennsylvania Attorney General Josh Shapiro said.

“Pennsylvania lost 5,172 lives to overdoses in the last year alone, which is 14 Pennsylvanians a day. This settlement is going to provide resources to jumpstart programs that will change lives and impact families across our commonwealth who are struggling to find treatment and help for those struggling with substance abuse,” Shapiro said. “These funds will be earmarked to offer and expand life-saving treatment options, prioritizing the areas that have been most affected by this crisis.”

Read More